Page results
-
The UCLH Macmillan Support and Information Service Coffee Morning — a welcoming space for anyone affected by cancer or blood conditions to connect, share experiences, and find support.
-
Acute lymphoblastic leukaemia (ALL) is a form of cancer that affects the cells in the bone marrow, the soft material inside your bones.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
Your treatment for acute lymphoblastic leukaemia (ALL) will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.
-
To enable us to provide a quick response when you need it most, we have developed these Frequently Asked Questions (FAQs). We kindly ask you to read through these before contacting our team as you may find the answer to your question here.
-
UCLH Charity is delighted to announce a generous £1.5 million donation from the Bukhman Philanthropies.
-
This page provides information for pregnant women with Inflammatory Bowel Disease.
-
The psychology team at UCLH are running the next 'Navigating the exam period' group on Wednesday 19 February, from 1pm - 4pm.
-
A new research project spearheaded by the CCTU at UCLH is trying to make more places on clinical trials available to young cancer patients aged between 16 and 24 years.
-
In a joint public appearance, the trio, who are Honorary Patrons of Teenage Cancer Trust, visited the ward to meet young patients and thank staff for their work.
File results
-
FOI/2022/0300 - EPRR Coordination of emergency/disaster management activities
-
FOI/2022/0302 - Treatment with conditions for rheumatology/ dermatology
-
FOI/2022/0304 - Histopathology labs that run immunohistochemistry diagnostic testing
-
FOI/2022/0305 - Ethnic minority categories used for Gypsy, Roma, Traveller groups
-
FOI/2022/0306 - Policy and associates procedure using robotics
-
FOI/2022/0309 - In-patient deaths
-
FOI/2022/0314 - Use of herbicide containing glyphosate on hospital grounds
-
FOI/2022/0315 - Role of patient safety specialists within the Trust
-
FOI/2022/0317 - Inpatient mental health facilities
-
FOI/2022/0318 - HIMMS Electronic Medical Record Adoption Model (EMRAM) level achieved at Trust